- Trials with a EudraCT protocol (362)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
362 result(s) found for: Placebo cream.
Displaying page 6 of 19.
EudraCT Number: 2012-005627-32 | Sponsor Protocol Number: IIVOP | Start Date*: 2014-06-12 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge | |||||||||||||
Full Title: A randomised, double blind, placebo controlled crossover study of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model - an enriched population study | |||||||||||||
Medical condition: Neuropathic Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002843-18 | Sponsor Protocol Number: AS3201-G000-291 | Start Date*: 2009-09-21 | |||||||||||
Sponsor Name:Eisai Limited | |||||||||||||
Full Title: A 2-year, Randomized, Double-blind, Placebo-controlled, Multi-center, Phase II-III Study to Evaluate the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimo... | |||||||||||||
Medical condition: Diabetic Sensorimotor Polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) EE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003953-34 | Sponsor Protocol Number: 101-001 | Start Date*: 2009-12-14 |
Sponsor Name:D2 Derma Europe Ltd. | ||
Full Title: A randomized, placebo-controlled, active comparator, observer-blinded multicentre phase II trial to evaluate the efficacy and safety of D2D001 in the treatment of HSV type 1 infection in the region... | ||
Medical condition: Herpes simplex virus type 1 infection in the region of the mouth and the openings of the nose | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001175-38 | Sponsor Protocol Number: 6520-9170-08 | Start Date*: 2012-01-13 |
Sponsor Name:MEDICE Arzneimittel Pütter GmbH & CO.KG | ||
Full Title: A multi-center, randomized, double-blind,phase II trial with intraindividual comparison to assess superiority of Soventol HydroCort 0.5 % Cremogel vs vehicle on lesional skin in patients with mild ... | ||
Medical condition: manifest atopic dermatitis diagnosed according to Hanifin and Rajka, or seborrheic eczema or stasis dermatitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-000842-23 | Sponsor Protocol Number: AdAM_2017 | Start Date*: 2018-02-19 |
Sponsor Name:Medical University Innsbruck | ||
Full Title: Adjuvante Imiquimod Therapie zur Senkung der Rezidivrate nach operativer Therapie bei analen HPV-Läsionen | ||
Medical condition: anal HPV-lesions | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-000700-14 | Sponsor Protocol Number: 2 | Start Date*: 2019-07-08 |
Sponsor Name:Medical University Graz | ||
Full Title: Pilot-Study comparing analgosedation concepts during placement of regional anaesthesia with either fentanyl, remifentanil, clonidine, EMLA-Patch or placebo in regard of patient's wellbeing, pain an... | ||
Medical condition: Patient with elective orthopedic surgery that will be administered a regional anaesthesia will be subject of the investigation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005042-37 | Sponsor Protocol Number: P-AG-E-4 | Start Date*: 2013-05-10 |
Sponsor Name:Bionorica SE | ||
Full Title: Prospective, double-blind, placebo-controlled, parallel-group, multi-centre randomized clinical trial to proof efficacy and safety of 20 mg (2 tablets of 10 mg) VAC BNO 1095 FCT in patients sufferi... | ||
Medical condition: Cyclic mastodynia and PMS | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Prematurely Ended) PL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-000898-83 | Sponsor Protocol Number: ADN016 | Start Date*: 2021-11-10 | |||||||||||
Sponsor Name:ADIENNE SA | |||||||||||||
Full Title: A phase II, randomized, double-blind, placebo-controlled, two-period, crossover trial to assess the efficacy and safety of begelomab in combination with standard steroid and/or immunosuppressant th... | |||||||||||||
Medical condition: Dermatomyositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002228-40 | Sponsor Protocol Number: A3191193 | Start Date*: 2006-08-28 |
Sponsor Name:PFIZER | ||
Full Title: A PHASE III PLACEBO-CONTROLLED TRIAL OF CELECOXIB IN GENOTYPE POSITIVE SUBJECTS WITH FAMILIAL ADENOMATOUS POLYPOSIS | ||
Medical condition: FAMILIAL ADENOMATOUS POLYPOSIS (FAP) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) SE (Completed) IT (Prematurely Ended) GB (Completed) CZ (Prematurely Ended) BE (Prematurely Ended) DE (Completed) HU (Prematurely Ended) SK (Completed) BG (Not Authorised) | ||
Trial results: View results |
EudraCT Number: 2015-000934-31 | Sponsor Protocol Number: INN-TOP-005 | Start Date*: 2015-07-10 | |||||||||||
Sponsor Name:Innocoll Pharmaceuticals Limited | |||||||||||||
Full Title: A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination with Systemic Antibiotic Therapy in Diabetic Pa... | |||||||||||||
Medical condition: Diabetic Patients with an Infected Foot Ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DE (Completed) AT (Completed) BE (Completed) ES (Completed) SK (Completed) NL (Completed) GB (Completed) PL (Completed) HU (Completed) DK (Completed) LV (Completed) LT (Completed) EE (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005492-25 | Sponsor Protocol Number: PrEP-CS-003 | Start Date*: 2016-03-10 | |||||||||||
Sponsor Name:PrEP Biopharm Ltd. | |||||||||||||
Full Title: A phase IIa, randomised, double-blind, placebo-controlled study using outpatient setting to investigate the duration of effect and evaluate further safety of PrEP-001 given prophylactically in heal... | |||||||||||||
Medical condition: Human Rhinovirus (HRV-16) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002523-16 | Sponsor Protocol Number: Ps02-S2006 | Start Date*: 2006-10-13 | |||||||||||
Sponsor Name:Synphora AB | |||||||||||||
Full Title: | |||||||||||||
Medical condition: Patients with mild to moderate plaque psoriasis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002835-27 | Sponsor Protocol Number: DRP-05-12 | Start Date*: 2012-09-07 |
Sponsor Name:Dr. Ritsert Pharma | ||
Full Title: Double-blind, randomized clinical study to determine the efficacy of Anestherit® 10% on histamine-induced pruritus and UVB-light induced slight sunburn in healthy subjects. | ||
Medical condition: Histamine-induced pruritus UVB-light-induced slight sunburn | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-021928-96 | Sponsor Protocol Number: ISD-LAM-2010-01 | Start Date*: 2011-04-01 | |||||||||||
Sponsor Name:ISDIN S.A. | |||||||||||||
Full Title: Ensayo clínico multicéntrico, doble ciego, para evaluar la eficacia y seguridad de lambdalina vs placebo como anestésico en fotodepilación con láser | |||||||||||||
Medical condition: Anestesia en Fotodepilación | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000809-23 | Sponsor Protocol Number: AB12003 | Start Date*: 2014-10-10 |
Sponsor Name:AB Science | ||
Full Title: A prospective, multicenter, randomized, double blind, placebo-controlled, 2-parallel groups, phase 3 study to compare the efficacy and safety of masitinib in combination with docetaxel to placebo i... | ||
Medical condition: metastatic Castrate Resistant Prostate Cancer (mCRPC). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: ES (Restarted) SK (Prohibited by CA) GR (Completed) CZ (Completed) GB (Temporarily Halted) IT (Suspended by CA) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004474-29 | Sponsor Protocol Number: NPJ5004-04/2011(SDS) | Start Date*: 2012-01-10 | |||||||||||
Sponsor Name:Norgine Ltd. | |||||||||||||
Full Title: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of TZP-101 (IV Ulimorelin) Administered Post-Operatively in Patients Who Have Undergone Partial Bowel Resection | |||||||||||||
Medical condition: Post-operative ileus in subjects who have undergone partial bowel resection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) LT (Prematurely Ended) CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023228-26 | Sponsor Protocol Number: TZP-101-CL-P007 | Start Date*: 2011-02-18 | |||||||||||
Sponsor Name:Tranzyme, Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Ulimorelin Administered Post-Operatively to Accelerate Recovery of Gastroin... | |||||||||||||
Medical condition: post-operative ileus in subjects who have undergone partial bowel resection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004222-25 | Sponsor Protocol Number: AB11003 | Start Date*: 2013-11-26 | |||||||||||
Sponsor Name:AB Science | |||||||||||||
Full Title: A 12-week with possible extension, prospective, multicenter, randomised, double-blind, controlled, 4-parallel groups, phase 2b/3 study to compare efficacy and safety of masitinib to placebo, in the... | |||||||||||||
Medical condition: Crohn's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) SK (Prohibited by CA) GR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001282-24 | Sponsor Protocol Number: REVCS002 | Start Date*: 2017-06-21 | |||||||||||
Sponsor Name:ReViral Ltd | |||||||||||||
Full Title: A Randomised, Phase 2a, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of Multiple Doses of RV521 Against Respiratory Syncytial Virus infecti... | |||||||||||||
Medical condition: Respiratory Syncytial Virus Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005244-95 | Sponsor Protocol Number: ALA116402 | Start Date*: 2012-06-27 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Limited | |||||||||||||
Full Title: A multi-national, randomized, double-blind, placebo-controlled, 3-period crossover study with GSK 573719 as monotherapy in adult subjects with asthma | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
